Net gamma exposure for Biogen Inc (BIIB) options was positive at the Nov 4, 2026 close, about $1.18M per 1% move in the stock. It has been positive on 17 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for BIIB, 2026-11-06(w), calls & puts
Gamma Exposure Stats
Showing results for BIIB, 2026-11-06(w), calls & puts
Net Gamma Exposure by Expiration
Showing results for BIIB, 2026-11-06(w), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
BIIB Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is BIIB gamma exposure positive or negative?
Biogen net gamma exposure was positive on Nov 4, 2026, at $1.18M. It has been positive on 17 of the last 20 trading days.
How has BIIB gamma exposure changed recently?
Biogen net gamma exposure went from $5.67M on Oct 7, 2026 to $1.18M on Nov 4, 2026. See the BIIB gamma exposure history for a longer view.
What is Biogen Inc?
Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases.